Your browser doesn't support javascript.
loading
Hypercapnia: An Aggravating Factor in Asthma.
Shigemura, Masahiko; Homma, Tetsuya; Sznajder, Jacob I.
Afiliación
  • Shigemura M; Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA.
  • Homma T; Department of Allergology and Respiratory Medicine, University of Showa School of Medicine, Tokyo 142-0064, Japan.
  • Sznajder JI; Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA.
J Clin Med ; 9(10)2020 Oct 05.
Article en En | MEDLINE | ID: mdl-33027886
Asthma is a common chronic respiratory disorder with relatively good outcomes in the majority of patients with appropriate maintenance therapy. However, in a small minority, patients can experience severe asthma with respiratory failure and hypercapnia, necessitating intensive care unit admission. Hypercapnia occurs due to alveolar hypoventilation and insufficient removal of carbon dioxide (CO2) from the blood. Although mild hypercapnia is generally well tolerated in patients with asthma, there is accumulating evidence that elevated levels of CO2 can act as a gaso-signaling molecule, triggering deleterious effects in various organs such as the lung, skeletal muscles and the innate immune system. Here, we review recent advances on pathophysiological response to hypercapnia and discuss potential detrimental effects of hypercapnia in patients with asthma.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos